Tango Therapeutics, Inc. logo TNGX - Tango Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $34.83 DETAILS
HIGH: $55.00
LOW: $24.00
MEDIAN: $31.50
CONSENSUS: $34.83
UPSIDE: 72.08%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 53.8 3.2 5.4 4.1 11.6 19.9 6.5 5.4 10.7 14.6 5.8 6.4 6.9 5.8 5.8 5.7 6.8 18.2 6.4 9.1 (11.3) 5.1 4.7
Cost of Revenue 0.5 0.5 0 0.6 0 0 0 0 0 0 0.6 1.5 1.5 1.5 1.2 0.7 0.7 0.6 21.9 0.5 0.4 0.4 13.0 11.1 10.8
Gross Profit (0.5) (0.5) 53.8 2.6 5.4 4.1 11.6 19.9 6.5 5.4 10.1 13.1 4.3 5.0 5.7 5.1 5.1 5.1 (15.1) 17.7 5.9 8.7 (24.2) (6.1) (6.1)
Operating Expenses
R&D Expenses 33.1 33.3 30.8 32.2 36.4 33.9 33.3 38.7 38.1 31.3 27.1 28.7 28.0 29.1 28.7 23.7 24.3 21.6 21.9 19.1 15 15.1 13.0 11.1 10.8
SG&A Expenses 15.2 9.8 8.9 11.3 11.5 11.1 11.2 10.8 10.7 9.1 8.6 7.7 6.6 6.4 6.9 6.5 6.1 5.5 4.4 3.2 3.0 2.6 2.5 2.4 2.0
Other Expenses 0 (1.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (21.9) 0 0 0 (13.0) (11.1) (10.8)
Operating Expenses 48.3 41.4 39.7 43.5 47.9 45.0 44.5 49.4 48.7 40.4 35.7 36.3 34.6 35.5 35.6 30.3 30.5 27.1 4.4 22.2 18.0 17.7 2.5 2.4 2.0
Operating Income
Operating Income (48.8) (41.9) 14.1 (41.0) (42.5) (40.9) (32.9) (29.6) (42.3) (35.0) (25.6) (23.2) (30.3) (30.6) (29.9) (25.2) (25.4) (22.0) (19.6) (4.6) (12.1) (8.9) (26.8) (8.4) (8.1)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0
Interest Income 2.2 1.7 1.1 1.2 1.6 1.8 1.8 2.1 2.2 2.2 1.9 1.4 1.1 0.6 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0 0 0.1
Profitability
EBITDA (48.3) (41.4) 14.6 (38.2) (41.9) (40.3) (32.3) (28.9) (41.6) (34.4) (21.6) (19.1) (26.6) (27.6) (27.8) (24.2) (24.5) (21.3) (19.3) (4.1) (11.6) (8.4) (26.6) (8.3) (7.9)
EBIT (48.8) (41.9) 14.1 (38.8) (42.5) (40.9) (32.9) (29.6) (42.3) (35.0) (22.2) (20.6) (28.0) (29.0) (29.1) (24.9) (25.2) (21.9) (19.6) (4.5) (12.0) (8.9) (26.8) (8.4) (8.1)
Income Before Tax (45.5) (38.8) 15.9 (38.8) (39.8) (37.6) (29.1) (25.5) (37.9) (30.7) (22.2) (20.6) (28.0) (29.0) (29.1) (24.9) (25.2) (21.9) (19.5) (4.5) (12.0) (8.9) (26.8) (8.4) (7.9)
Income Tax Expense 0.0 (0.1) (0.0) 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0 0.1 0 0.0 0 0.2 0.1 (0.0) 0.1 0 0 0 0
Net Income (45.5) (38.7) 15.9 (38.9) (39.9) (37.7) (29.2) (25.6) (37.9) (30.8) (22.3) (20.7) (28.0) (29.1) (29.1) (24.9) (25.2) (22.0) (19.6) (4.5) (12.1) (8.9) (26.8) (8.4) (7.9)
Per Share Data
EPS (Basic) -0.32 -0.30 0.14 -0.35 -0.36 -0.34 -0.27 -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 -0.53 -0.00 -0.75 -0.74
EPS (Diluted) -0.32 -0.30 0.14 -0.35 -0.36 -0.34 -0.27 -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 -0.42 -0.00 -0.75 -0.74
Shares Outstanding 143.6 116.2 111.0 110.5 110.3 108.7 108.5 108.3 108.2 95.8 97.0 88.4 88.2 88.0 87.9 87.8 87.7 87.6 70.2 87.5 87.5 87.5 87.5 87.5 87.5
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Current Assets
Cash & Cash Equivalents 157.8 112.3 58.3 39.3 58.4 69.5 53.1 51.6 61.2 66.4 58.5 66.1 57.3 60.0 100.3 104.6 99.9 142.7 205.0 50.9 65.8 28.4 1.6 0.0 (40.4)
Short-Term Investments 222.0 230.9 94.5 141.5 158.3 188.4 240.1 270.5 282.4 270.5 301.3 244.6 276.4 306.2 293.0 311.8 350.0 342.5 298.8 147.5 141.1 161.9 0 0 80.8
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 2 2 2 8 2 2 2 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 12.5 10.6 0.4 9.3 8.2 8.4 7.5 6.3 8.4 9.7 11.0 9.9 9.4 7.1 0.6 0.6 0.6 0.6 0 0 0 0 0 0 0
Total Current Assets 392.3 353.8 163.8 190.1 224.9 266.3 300.8 328.4 352.0 346.5 370.9 320.5 343 375.3 401.7 436.1 460.7 492.3 516.3 202.1 210.4 193.6 1.6 0.0 40.4
Non-Current Assets
Property, Plant & Equipment 41.0 42.5 43.9 45.3 47.2 47.6 49.0 50.5 51.6 53.4 54.7 56.2 57.3 57.8 59.1 8.9 7.4 6.1 11.4 11.4 11.1 11.3 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 166.8 0 0
Other Non-Current Assets 2.4 2.4 2.4 2.4 2.1 2.6 2.6 2.6 2.6 2.6 2.6 2.6 3.4 3.4 3.4 3.4 3.4 1.7 2.4 3.8 2.7 2.3 0 0.0 (40.4)
Total Non-Current Assets 43.5 44.9 46.4 47.8 49.4 50.1 51.6 53.0 54.2 56.0 57.3 58.8 60.8 61.2 62.5 12.3 10.9 7.8 13.8 15.2 13.8 13.6 166.8 0.0 (40.4)
Total Assets 435.8 398.7 210.1 237.9 274.3 316.5 352.4 381.5 406.2 402.6 428.2 379.3 403.8 436.5 464.2 448.4 471.5 500.2 530.1 217.2 224.1 207.3 168.4 0.1 0
Current Liabilities
Account Payables 2.4 1.2 2.2 2.6 3.2 1.6 4.1 1.1 3.9 2.8 2.8 4.8 6.3 4.5 6.3 1.7 3.4 3.2 3.1 5.2 4.5 1.8 0 0 0
Short-Term Debt 2.8 2.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0
Deferred Revenue 0 0 0 23.4 19.5 17.6 15.6 23.7 23.1 25.7 27.1 33.8 34.0 31.8 28.5 28.2 25.0 26.0 27.8 0 0 32.0 0 0 0
Other Current Liabilities 9.1 17.8 1.7 2.0 2.0 1.7 2.7 1.5 2.0 1.3 1.4 1.6 1.5 1.3 1.8 0.9 0.9 0.7 1.1 25.2 27.1 0.8 0.1 0.0 0
Total Current Liabilities 14.3 21.7 18.4 40.0 35.9 38.2 37.6 43.9 42.8 45.9 43.4 53.6 53.7 55.5 51.3 44.7 39.2 40.7 42.0 37.2 36.9 40.9 0.1 0.0 0
Non-Current Liabilities
Long-Term Debt 30.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 118.7 122.7 0.0 5.8 0 0
Total Non-Current Liabilities 30.0 30.8 31.7 62.9 71.6 78.8 85.7 89.9 99.0 103.5 108.2 112.8 122.8 131.4 139.8 105.0 112.0 114.7 122.7 125.1 129.4 127.7 5.8 0 0
Total Liabilities 44.3 52.5 50.1 102.9 107.5 117.0 123.2 133.8 141.8 149.5 151.6 166.4 176.5 187.0 191.1 149.7 151.2 155.4 164.7 162.3 166.2 168.7 6.0 0.0 0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 157.4 0.0 0
Retained Earnings (648.7) (603.2) (564.4) (580.3) (541.4) (501.6) (463.9) (434.7) (409.2) (371.3) (340.5) (318.2) (297.5) (269.5) (240.5) (211.4) (186.5) (161.3) (139.3) (119.7) (115.2) (103.1) (0.1) (0.0) 0
Accumulated Other Comprehensive Income (0.1) 0.2 0.1 0.1 0.2 0.3 0.8 (0.3) (0.3) 0.2 (0.7) (1.5) (2.2) (3.7) (4.9) (4.3) (3.4) (0.8) (0.0) 0.0 0.0 0.0 0 0 (47.8)
Total Stockholders' Equity 391.5 346.2 160.0 135.0 166.8 199.5 229.2 247.7 264.5 253.1 276.6 212.9 227.3 249.5 273.1 298.7 320.4 344.7 365.4 54.9 57.9 38.6 162.4 0.0 7.9
Total Liabilities & Equity 435.8 398.7 210.1 237.9 274.3 316.5 352.4 381.5 406.2 402.6 428.2 379.3 403.8 436.5 464.2 448.4 471.5 500.2 530.1 217.2 224.1 207.3 168.4 0.1 7.9
Debt Metrics
Total Debt 32.8 33.6 34.8 35.0 36.9 36.5 37.6 37.8 38.2 38.9 39.5 39.9 41.4 41.1 40.7 0.6 1.1 1.5 7.2 7.4 7.5 7.9 0 0.0 0
Net Debt (125.0) (78.7) (23.6) (4.3) (21.5) (33.0) (15.5) (13.7) (22.9) (27.5) (19.0) (26.2) (15.9) (18.8) (59.6) (104.0) (98.8) (141.2) (197.8) (43.5) (58.3) (20.5) (1.6) 0.0 40.4
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (45.5) (38.7) 15.9 (38.9) (39.9) (37.7) (29.2) (25.6) (37.9) (30.8) (22.3) (20.7) (28.0) (29.1) (29.1) (24.9) (25.2) (22.0) (19.6) (4.5) (12.1) (8.9) (26.8) (8.4) (7.9)
Depreciation & Amortization 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Stock-Based Compensation 10.8 6.0 6.6 6.6 7.3 7.5 7.2 7.5 6.7 4.9 4.9 5.1 4.2 3.8 3.8 3.4 3.2 2.3 3.4 1.2 0.9 0.5 0.4 0.4 0.4
Change in Working Capital (10.0) 2.4 (54.4) (5.2) (10.0) (7.1) (11.8) (6.0) (6.8) (0.8) (16.0) (9.5) (11.7) (4.0) 4.6 (10.8) (8.4) 2.2 (5.9) (4.7) (3.0) (10.2) 1.8 1.4 (1.4)
Other Non-Cash Items (0.1) 0.2 0.4 0.3 0.3 0.1 (0.2) (0.2) (0.5) (1.4) 1.7 0.0 (0.0) 0.4 0.6 0.3 0.4 0.4 0.3 0.3 0.3 0.3 135.7 (4.6) (3.4)
Operating Cash Flow (44.4) (29.7) (31.0) (36.5) (41.7) (36.6) (33.4) (23.6) (37.9) (27.5) (31.1) (24.5) (34.9) (28.3) (19.6) (31.5) (29.7) (16.9) (21.5) (7.5) (13.6) (18.1) 111.3 (11.0) (12.1)
Investing Activities
Capital Expenditure 0.0 (0.2) (0.2) (0.6) (0.1) (0.1) (0.1) (0.3) (0.2) (0.2) (0.0) (0.7) (0.6) (1.0) (3.3) (1.8) (1.6) (0.7) (0.8) (0.2) (0.2) (0.5) (0.1) (0.5) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (54.4) (175.0) (18.3) (23.9) (47.2) (32.5) (39.5) (48.6) (120.3) (51.0) (156.2) (50.8) (52.5) (93.6) (44.5) (15.9) (54.6) (104.4) (181.9) (66.2) (19.9) (105.6) 0 0 0
Sales/Maturities of Investments 64.0 39.5 66.0 41.3 77.8 84.7 72.2 61.6 109.3 85.1 99.6 84.1 84.7 82.0 63.0 53.2 44.4 59.9 30.4 59.8 40.6 46.9 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (69.6) (27.9) 11.9
Investing Cash Flow 9.6 (135.7) 47.5 16.8 30.6 52.1 32.6 12.7 (11.2) 33.9 (56.7) 32.7 31.6 (12.6) 15.2 35.5 (11.7) (45.2) (152.2) (6.6) 20.6 (59.2) (69.7) (28.4) 11.9
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.5) (0.0) 0 0 0.0 1.0 2.4 1.3 1.3 1.5 0.4 0.6 0.1 0.5 0.1 0.7 0.3 (0.1) 327.8 (0.7) 0.4 0.0 51.1 29.9 0
Financing Cash Flow 79.8 219.4 2.5 0.6 0.0 1.0 2.4 1.3 43.0 1.5 80.3 0.6 0.1 0.5 0.1 0.7 0.3 (0.1) 327.8 (0.7) 30.4 (0.1) 51.1 29.9 0
Cash Position
Net Change in Cash 45.1 53.9 19.1 (19.2) (11.1) 16.4 1.6 (9.6) (6.1) 7.9 (7.5) 8.8 (3.3) (40.3) (4.3) 4.7 (41.1) (62.2) 154.1 (14.9) 37.4 (77.3) 92.6 (9.5) (0.2)
Cash at Beginning 114.8 60.9 39.7 61.0 72.1 55.7 54.1 63.7 69.8 62.0 69.5 60.7 64.0 104.3 108.6 103.9 145.0 207.3 53.2 68.1 30.7 108.0 15.4 24.9 25.2
Cash at End 160.0 114.8 58.8 41.8 61.0 72.1 55.7 54.1 63.7 69.8 62.0 69.5 60.7 64.0 104.3 108.6 103.9 145.0 207.3 53.2 68.1 30.7 108.0 15.4 24.9
Free Cash Flow (44.4) (29.9) (31.1) (37.1) (41.7) (36.8) (33.5) (23.9) (38.1) (27.7) (31.2) (25.1) (35.5) (29.3) (22.9) (33.3) (31.2) (17.6) (22.3) (7.7) (13.8) (18.5) 111.1 (11.5) (12.2)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 53.8 3.2 5.4 4.1 11.6 19.9 6.5 5.4 10.7 14.6 5.8 6.4 6.9 5.8 5.8 5.7 6.8 18.2 6.4 9.1 (11.3) 5.1 4.7
Gross Profit (0.5) (0.5) 53.8 2.6 5.4 4.1 11.6 19.9 6.5 5.4 10.1 13.1 4.3 5.0 5.7 5.1 5.1 5.1 (15.1) 17.7 5.9 8.7 (24.2) (6.1) (6.1)
Operating Income (48.8) (41.9) 14.1 (41.0) (42.5) (40.9) (32.9) (29.6) (42.3) (35.0) (25.6) (23.2) (30.3) (30.6) (29.9) (25.2) (25.4) (22.0) (19.6) (4.6) (12.1) (8.9) (26.8) (8.4) (8.1)
Net Income (45.5) (38.7) 15.9 (38.9) (39.9) (37.7) (29.2) (25.6) (37.9) (30.8) (22.3) (20.7) (28.0) (29.1) (29.1) (24.9) (25.2) (22.0) (19.6) (4.5) (12.1) (8.9) (26.8) (8.4) (7.9)
EPS (Diluted) -0.32 -0.30 0.14 -0.35 -0.36 -0.34 -0.27 -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 -0.42 -0.00 -0.75 -0.74
Balance Sheet
Cash & Equivalents 157.8 112.3 58.3 39.3 58.4 69.5 53.1 51.6 61.2 66.4 58.5 66.1 57.3 60.0 100.3 104.6 99.9 142.7 205.0 50.9 65.8 28.4 1.6 0.0 (40.4)
Total Assets 435.8 398.7 210.1 237.9 274.3 316.5 352.4 381.5 406.2 402.6 428.2 379.3 403.8 436.5 464.2 448.4 471.5 500.2 530.1 217.2 224.1 207.3 168.4 0.1 0
Total Debt 32.8 33.6 34.8 35.0 36.9 36.5 37.6 37.8 38.2 38.9 39.5 39.9 41.4 41.1 40.7 0.6 1.1 1.5 7.2 7.4 7.5 7.9 0 0.0 0
Stockholders' Equity 391.5 346.2 160.0 135.0 166.8 199.5 229.2 247.7 264.5 253.1 276.6 212.9 227.3 249.5 273.1 298.7 320.4 344.7 365.4 54.9 57.9 38.6 162.4 0.0 7.9
Cash Flow
Operating Cash Flow (44.4) (29.7) (31.0) (36.5) (41.7) (36.6) (33.4) (23.6) (37.9) (27.5) (31.1) (24.5) (34.9) (28.3) (19.6) (31.5) (29.7) (16.9) (21.5) (7.5) (13.6) (18.1) 111.3 (11.0) (12.1)
Capital Expenditure 0.0 (0.2) (0.2) (0.6) (0.1) (0.1) (0.1) (0.3) (0.2) (0.2) (0.0) (0.7) (0.6) (1.0) (3.3) (1.8) (1.6) (0.7) (0.8) (0.2) (0.2) (0.5) (0.1) (0.5) (0.0)
Free Cash Flow (44.4) (29.9) (31.1) (37.1) (41.7) (36.8) (33.5) (23.9) (38.1) (27.7) (31.2) (25.1) (35.5) (29.3) (22.9) (33.3) (31.2) (17.6) (22.3) (7.7) (13.8) (18.5) 111.1 (11.5) (12.2)